Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes.
Farsad AfshinniaEvan L ReynoldsThekkelnaycke M RajendiranTanu SoniJaeman ByunMasha Georges SavelieffHelen C LookerRobert G NelsonGeorge MichailidisBrian Christopher CallaghanSubramaniam PennathurEva L FeldmanPublished in: Annals of clinical and translational neurology (2022)
Abundance differences in circulating acylcarnitines, free fatty acids, phosphatidylcholines, and lysophosphatidylcholines 10 years prior to neuropathy assessment are associated with neuropathy status in type 2 diabetes.